Menu Search
Equities

Spire Healthcare Group PLC

S00:DEU

Spire Healthcare Group PLC

Actions
  • Price (EUR)2.90
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+17.89%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom (UK) and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart treatments, neurosurgery and neurology, hip and knee, kidney treatments, physiotherapy, podiatry, respiratory medicine, scans and investigations, skin treatments, spinal surgery and treatments, sports science, vascular surgery, weight loss, women's health, and others. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.

  • Revenue in GBP (TTM)1.36bn
  • Net income in GBP26.80m
  • Incorporated2014
  • Employees16.80k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SPI:LSE since
announced		Transaction
value
RehabWorks LtdDeal completed19 Oct 202319 Oct 2023Deal completed14.12%89.84m
Data delayed at least 20 minutes, as of May 01 2024 12:49 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.